Your search returned 10 results.

Results
	1.	Supporting evidence from optical coherence tomography for shortening dual antiplatelet therapy after drug-eluting stents implantation. [Review] MedStar authors: Garcia-Garcia, Hector M Mintz, Gary S Ozaki, Yuichi Waksman, Ron PMID: 32321328 Year: 2020 Citation: Expert Review of Cardiovascular Therapy. 18(5):261-267, 2020 May. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Garcia-Garcia HM, Mintz GS, Ozaki Y, Waksman R DOI: https://dx.doi.org/10.1080/14779072.2020.1759421 Add to cart (remove)
	2.	Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study. MedStar authors: Brar, Gagandeep PMID: 27696084 Year: 2017 Citation: Journal of Thrombosis & Thrombolysis. 43(2):166-171, 2017 Feb Institution: MedStar Washington Hospital Center Department: Hematology/Oncology Medline publication type: Journal Article Validation Studies Form of publication: Journal Article All authors: Brar G, Harnicar S, Laube E, Mantha S, Miao Y, Parameswaran R, Samedy P, Sarasohn DM, Soff GA, Stefanik S, Wills J DOI: https://dx.doi.org/10.1007/s11239-016-1429-1 Add to cart (remove)
	3.	Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT. MedStar authors: Barnett, Christopher F PMID: 36036760 Year: 2022 Citation: Circulation. 146(18):1344-1356, 2022 Nov. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Babar I, Baird-Zars V, Barnett CF, Berg DD, Bohula EA, Chaudhry SP, Chopra A, Connors JM, COVID-PACT Investigators, Ginete W, Ieong MH, Katz JN, Kim EY, Kuder JF, Lopes MS, Mazza E, McLean D, Morrow DA, Mosier JM, Moskowitz A, Murphy SA, O'Donoghue ML, Park JG, Prasad R, Ruff CT, Sabatine MS, Shahrour MN, Sinha SS, Van Diepen S, Wiviott SD, Zainea M DOI: https://dx.doi.org/10.1161/CIRCULATIONAHA.122.061533 Add to cart (remove)
	4.	Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials. MedStar authors: Baker, Nevin C Escarcega, Ricardo O Lhermusier, Thibault Lipinski, Michael J Magalhaes, Marco A Pichard, Augusto D Satler, Lowell F Suddath, William O Torguson, Rebecca Waksman, Ron PMID: 25440505 Year: 2014 Citation: Cardiovascular Revascularization Medicine. 15(6-7):315-22, 2014 Sep-Oct. Institution: MedStar Heart & Vascular Institute Medline publication type: Comparative Study Journal Article Meta-Analysis Form of publication: Journal Article All authors: Baker NC, Escarcega RO, Lhermusier T, Lipinski MJ, Magalhaes MA, Pichard AD, Satler LF, Suddath WO, Torguson R, Waksman R Add to cart (remove)
	5.	Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III). MedStar authors: Dvir, Danny Swymelar, Stacy Torguson, Rebecca Waksman, Ron Xue, Zhenyi PMID: 23240743 Year: 2013 Citation: Journal of Interventional Cardiology. 26(2):107-13, 2013 Apr. Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bertrand O, Driesman M, Dvir D, Gruberg L, Mehta S, Rossi J, Swymelar S, Torguson R, Waksman R, Xue Z DOI: http://dx.doi.org/10.1111/joic.12005 Add to cart (remove)
	6.	Catheter-directed thrombolysis vs. anticoagulation for the prevention and treatment of post-thrombotic syndrome in deep vein thrombosis: An updated systematic review and meta-analysis of randomized trials. MedStar authors: Bikakis, Iosif Jonnalagadda, Anil K PMID: 30871438 Year: 2019 Citation: Phlebology. 34(10):675-682, 2019 Dec. Institution: MedStar Heart & Vascular Institute MedStar Washington Hospital Center Department: Medicine/General Internal Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Archontakis-Barakakis P, Bakoyiannis C, Bikakis I, Faillace RT, Jonnalagadda AK, Kokkinidis DG, Mastoris I, Palaiodimos L, Papanastasiou CA, Schizas D DOI: https://dx.doi.org/10.1177/0268355519835618 Add to cart (remove)
	7.	Safety of bivalirudin in percutaneous coronary intervention following thrombolytic therapy. MedStar authors: Lindsay, Joseph Sardi, Gabriel L Waksman, Ron PMID: 22581418 Year: 2013 Citation: Catheterization & Cardiovascular Interventions. 82(4):614-20, 2013 Oct 1. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Lindsay J, Sardi GL, Waksman R DOI: http://dx.doi.org/10.1002/ccd.24478 Add to cart (remove)
	8.	Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study. MedStar authors: Garcia-Garcia, Hector M Soud, Mohamad Yacob, Omar PMID: 31883294 Year: 2020 Citation: Catheterization & Cardiovascular Interventions. 96(6):1156-1171, 2020 11. Institution: MedStar Heart & Vascular Institute MedStar Washington Hospital Center Department: Internal Medicine Residency Medline publication type: Journal Article Form of publication: Journal Article All authors: Adamo M, Ando G, Boccuzzi G, Briguori C, Calabro P, Contarini M, Diletti R, Frigoli E, Garcia-Garcia HM, Garducci S, Karagiannis A, Limbruno U, Palmieri C, Picchi A, Rigattieri S, Russo F, Sardella G, Soud M, Valgimigli M, Varbella F, Yacob O, Zimarino M DOI: https://dx.doi.org/10.1002/ccd.28661 Add to cart (remove)
	9.	Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention. [Review] MedStar authors: Waksman, Ron PMID: 31202949 Year: 2019 Citation: Jacc: Cardiovascular Interventions. 12(16):1521-1537, 2019 08 26. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Alexopoulos D, Angiolillo DJ, Aradi D, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, Sibbing D, So DYF, Stone GW, Storey RF, Tantry U, Ten Berg J, Trenk D, Valgimigli M, Waksman R DOI: https://dx.doi.org/10.1016/j.jcin.2019.03.034 Add to cart (remove)
	10.	Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis. [Review] MedStar authors: Gaglia, Michael AJ Garcia-Garcia, Hector M Lee, Regina C Lipinski, Michael J Pichard, Augusto D Satler, Lowell F Torguson, Rebecca Waksman, Ron PMID: 27842901 Year: 2016 Citation: Cardiovascular Revascularization Medicine. 17(8):535-545, 2016 Dec Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Meta-Analysis Review Form of publication: Journal Article All authors: Gaglia MA Jr, Garcia-Garcia HM, Lee RC, Lipinski MJ, Pichard AD, Satler LF, Torguson R, Waksman R DOI: https://dx.doi.org/10.1016/j.carrev.2016.09.011 Add to cart (remove)

Powered by Koha